CytoSorbents announces launch, availability of PuriFi Blood Pump in E.U.

CytoSorbents announces the launch and immediate availability of its PuriFi hemoperfusion machine in the E.U., following approval and certification under the E.U. Medical Device Regulation, MDR. Vincent Capponi, President and Chief Operating Officer of CytoSorbents said: “We are excited to launch the PuriFi pump, the result of a 2-year development program with our original equipment manufacturer partner, the Medica Group. Innovation is a key growth driver for us and the feature-rich, easy-to-use PuriFi pump exemplifies this. During the past year, we have been diligently preparing for this product launch, including extensive beta testing of the pumps, sales and technical training for both direct sales teams and select distributors, developing new marketing collateral, establishing a hardware and service maintenance program, prioritizing key sales targets, and working with Medica to ensure availability of machines and bloodlines under MDR. We are pleased to finally begin commercialization.”